Nanocell Therapeutics
Pharmaceutical Manufacturing • 
Utrecht, Utrecht, Netherlands • 11-20 Employees
Company overview
| Headquarters | Utrecht, Utrecht, Netherlands |
| Website | |
| NAICS | 3254 |
| Keywords | Biotechnology, Gene Therapy, In-Vivo Gene Therapy |
| Employees | 11-20 |
| Socials |
Key Contact at Nanocell Therapeutics
Jacek Lubelski
Chief Technology Officer
Nanocell Therapeutics Email Formats
Nanocell Therapeutics uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@nanocelltx.com), used 70% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@nanocelltx.com | 70% |
{first initial}{last name} | jdoe@nanocelltx.com | 30% |
About Nanocell Therapeutics
NanoCell Therapeutics is a privately-held biotechnology company with offices in King of Prussia, Pennsylvania, and Utrecht, the Netherlands. Our mission is to revolutionize in-vivo cell engineering through our groundbreaking non-viral, DNA-based gene therapy platform, primarily focusing on oncology and autoimmune diseases. At NanoCell, we’re driving innovation by transforming traditional adoptive cell therapy methods into advanced in-vivo treatments. Our ultimate goal is to simplify the treatment process, increasing patient accessibility, potential clinical benefits, and cost-effective manufacturing. We work both autonomously and in collaboration with partners to make substantial advancements in our targeted disease areas. For more information, visit http://www.nanocelltx.com).
Nanocell Therapeutics revenue & valuation
| Annual revenue | $1,368,880 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $4,400,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Nanocell Therapeutics has 3 employees across 3 departments.
Departments
Number of employees
Funding Data
Nanocell Therapeutics has never raised funding before.
New Zealand
United States
United Arab Emirates
CanadaFrequently asked questions
4.8
40,000 users
